Patents by Inventor Chirajyoti Deb

Chirajyoti Deb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240366196
    Abstract: A brush for biopsy may include a sheath and a shaft extending through a cavity of the sheath, where the shaft is moveable relative to the sheath. The brush may include a cap located at a distal end of the shaft, where the cap is configured to seal a distal end of the sheath. The brush may further include a set of bristles and at least two members attached to the shaft at locations proximal to the cap, where the at least two members are configured to seal the cavity when located within the sheath. A first member of the at least two members may be attached to the shaft at a location distal to the set of bristles, and a second member of the at least two members may be attached to the shaft at a location proximal to the set of bristles.
    Type: Application
    Filed: July 18, 2024
    Publication date: November 7, 2024
    Applicant: ORLANDO HEALTH, INC.
    Inventors: Yamen Smadi, Devendra Indulal Mehta, Chirajyoti Deb, Anthony Mango, Riham Mikhail Hanna, Evan Cuellar Gomez
  • Patent number: 8551499
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: October 8, 2013
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Patent number: 8241644
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: August 14, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Patent number: 8211446
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: July 3, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Patent number: 8039605
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: October 18, 2011
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel
  • Patent number: 8012492
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: April 22, 2008
    Date of Patent: September 6, 2011
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20110033914
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Application
    Filed: August 30, 2010
    Publication date: February 10, 2011
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20110033915
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Application
    Filed: August 30, 2010
    Publication date: February 10, 2011
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20100008903
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Application
    Filed: August 25, 2009
    Publication date: January 14, 2010
    Inventors: Pappachan E. Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel
  • Patent number: 7601357
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: October 13, 2009
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel
  • Publication number: 20090023596
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Application
    Filed: April 22, 2008
    Publication date: January 22, 2009
    Inventors: Pappachan Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20070161562
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Application
    Filed: November 20, 2006
    Publication date: July 12, 2007
    Inventors: Pappachan Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel